Independent Rx Forum cover art

Independent Rx Forum

Independent Rx Forum

Written by: National Community Pharmacists Association
Listen for free

About this listen

Welcome to Independent Rx Forum with RxConnexion and National Community Pharmacists Association. The leading advocate and business education resource for America's independent pharmacists.2024 Careers Economics Hygiene & Healthy Living Personal Success Physical Illness & Disease
Episodes
  • ICYMI #NCPA2025: Another Door to Behavioral Health
    Jan 20 2026

    Recorded live at #NCPA2025, host John Beckner and co-host Ed Cohen sit down with Oluwatoyin Fadeyibi, PharmD, director of pharmacy initiatives at Community Behavioral Health, and Andrew Patterson, professor of pharmacy at the Philadelphia College of Pharmacy, for a timely conversation on behavioral health. They discuss the ongoing shortages in mental health care, the growing role of community pharmacies, and how collaborative partnerships across Pennsylvania are helping pharmacies become another critical access point — or "door" — to behavioral health support.

    Show More Show Less
    15 mins
  • Inside the Newly Improved Community Pharmacy Fellowship
    Dec 20 2025

    Host John Beckner is joined by Drew Register, director of student affairs and professional development at NCPA, Charlotte Nazar, an executive resident at NCPA, and Tiffany Capps, practice transformations lead at CPESN®, to discuss the newly enhanced Community Pharmacy Fellowship from NCPA and CPESN. The conversation explores how the fellowship was developed, what's new in the program — including a stronger focus on medication synchronization — and what prospective applicants need to know before applications are due Jan. 31, 2026.

    Learn more about fellowship: https://ncpa.org/fellowship

    Show More Show Less
    39 mins
  • ICYMI #NCPA2025: Fair Pricing for Type 2 Diabetes Care
    Dec 16 2025

    Coming to you from the #NCPA2025 expo floor, host John Beckner and co-host Ed Cohen talk with Brian Connelly, president and CEO of TheracosBio, about Brenzavvy (bexagliflozin), an FDA-approved oral SGLT2 inhibitor for adults with Type 2 diabetes. They discuss how the company's model bypasses PBMs to offer pharmacists and patients a fair, transparent price.

    Show More Show Less
    15 mins
No reviews yet